Andreas Frey

2.4k total citations
41 papers, 1.9k citations indexed

About

Andreas Frey is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Andreas Frey has authored 41 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 14 papers in Radiology, Nuclear Medicine and Imaging and 10 papers in Immunology. Recurrent topics in Andreas Frey's work include Monoclonal and Polyclonal Antibodies Research (13 papers), Glycosylation and Glycoproteins Research (6 papers) and RNA Interference and Gene Delivery (5 papers). Andreas Frey is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (13 papers), Glycosylation and Glycoproteins Research (6 papers) and RNA Interference and Gene Delivery (5 papers). Andreas Frey collaborates with scholars based in Germany, United States and Czechia. Andreas Frey's co-authors include James Di Canzio, David Zurakowski, Marian R. Neutra, Barbara Meckelein, M. Alexander Schmidt, Paul J. Giannasca, Richard Weltzin, Wayne I. Lencer, Niels Röckendorf and Hubert Reggio and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and PLoS ONE.

In The Last Decade

Andreas Frey

40 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Frey Germany 19 770 411 258 184 157 41 1.9k
Noriko Tomita Japan 30 944 1.2× 490 1.2× 541 2.1× 197 1.1× 162 1.0× 117 2.5k
G.J. Russell-Jones Australia 13 1.5k 1.9× 452 1.1× 236 0.9× 208 1.1× 259 1.6× 15 2.8k
Nerida Cole Australia 32 603 0.8× 293 0.7× 111 0.4× 99 0.5× 452 2.9× 76 2.5k
Frida Svensson Sweden 17 1.3k 1.7× 280 0.7× 248 1.0× 141 0.8× 30 0.2× 22 2.2k
Kristina A. Thomsson Sweden 21 1.4k 1.9× 375 0.9× 207 0.8× 155 0.8× 73 0.5× 39 2.2k
Tao Hu China 22 630 0.8× 165 0.4× 169 0.7× 126 0.7× 113 0.7× 93 1.3k
Michelle Kilcoyne Ireland 26 1.2k 1.6× 257 0.6× 168 0.7× 134 0.7× 139 0.9× 82 2.3k
Andrea Ardizzoni Italy 21 986 1.3× 173 0.4× 357 1.4× 343 1.9× 92 0.6× 52 2.0k
J.A. Verschoor South Africa 21 392 0.5× 183 0.4× 347 1.3× 288 1.6× 108 0.7× 72 1.5k
Catherine Robbe‐Masselot France 24 1.6k 2.1× 308 0.7× 285 1.1× 149 0.8× 75 0.5× 51 2.3k

Countries citing papers authored by Andreas Frey

Since Specialization
Citations

This map shows the geographic impact of Andreas Frey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Frey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Frey more than expected).

Fields of papers citing papers by Andreas Frey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Frey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Frey. The network helps show where Andreas Frey may publish in the future.

Co-authorship network of co-authors of Andreas Frey

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Frey. A scholar is included among the top collaborators of Andreas Frey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Frey. Andreas Frey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Röckendorf, Niels, Karoline I. Gaede, Lars Lunding, et al.. (2024). Parallel detection of multiple biomarkers in a point-of-care-competent device for the prediction of exacerbations in chronic inflammatory lung disease. Scientific Reports. 14(1). 12830–12830. 1 indexed citations
2.
3.
Frey, Andreas, Lars Lunding, Johanna C. Ehlers, et al.. (2020). More Than Just a Barrier: The Immune Functions of the Airway Epithelium in Asthma Pathogenesis. Frontiers in Immunology. 11. 761–761. 150 indexed citations
4.
Homann, Arne, Niels Röckendorf, Arno Kromminga, et al.. (2017). Glycan and Peptide IgE Epitopes of the TNF-alpha Blockers Infliximab and Adalimumab - Precision Diagnostics by Cross-Reactivity Immune Profiling of Patient Sera. Theranostics. 7(19). 4699–4709. 18 indexed citations
5.
Röckendorf, Niels, et al.. (2017). Identification of novel antibody-reactive detection sites for comprehensive gluten monitoring. PLoS ONE. 12(7). e0181566–e0181566. 11 indexed citations
6.
Homann, Arne, Niels Röckendorf, Arno Kromminga, Andreas Frey, & Uta Jappe. (2015). B cell epitopes on infliximab identified by oligopeptide microarray with unprocessed patient sera. Journal of Translational Medicine. 13(1). 339–339. 18 indexed citations
7.
Frey, Andreas, et al.. (2014). Coating with luminal gut-constituents alters adherence of nanoparticles to intestinal epithelial cells. Beilstein Journal of Nanotechnology. 5. 2308–2315. 24 indexed citations
8.
Lautenschläger, Ingmar, et al.. (2014). The gut wall provides an effective barrier against nanoparticle uptake. Beilstein Journal of Nanotechnology. 5. 2092–2101. 27 indexed citations
9.
Röckendorf, Niels, et al.. (2012). Molecular Evolution of Peptide Ligands with Custom-Tailored Characteristics for Targeting of Glycostructures. PLoS Computational Biology. 8(12). e1002800–e1002800. 6 indexed citations
10.
Bade, Steffen, et al.. (2010). Quantitation of major protein constituents of murine intestinal fluid. Analytical Biochemistry. 406(2). 157–165. 4 indexed citations
11.
Reuter, Fabian, Steffen Bade, Timothy R. Hirst, & Andreas Frey. (2009). Bystander protein protects potential vaccine-targeting ligands against intestinal proteolysis. Journal of Controlled Release. 137(2). 98–103. 8 indexed citations
12.
Schwab, Matthias, Adrian Lupescu, Maria Moța, et al.. (2008). Association of SGK1 Gene Polymorphisms with Type 2 Diabetes. Cellular Physiology and Biochemistry. 21(1-3). 151–160. 52 indexed citations
13.
14.
Bade, Steffen, et al.. (2006). Prion protein 90-231 contains a streptavidin-binding motif. Biochemical and Biophysical Research Communications. 349(1). 296–302. 2 indexed citations
15.
Frey, Andreas, et al.. (2000). A stable and highly sensitive 3,3′,5,5′-tetramethylbenzidine-based substrate reagent for enzyme-linked immunosorbent assays. Journal of Immunological Methods. 233(1-2). 47–56. 226 indexed citations
16.
Frey, Andreas, et al.. (1999). Grafting Protein Ligand Monolayers onto the Surface of Microparticles for Probing the Accessibility of Cell Surface Receptors. Bioconjugate Chemistry. 10(4). 562–571. 4 indexed citations
17.
Frey, Andreas, James Di Canzio, & David Zurakowski. (1998). A statistically defined endpoint titer determination method for immunoassays. Journal of Immunological Methods. 221(1-2). 35–41. 463 indexed citations
18.
Frey, Andreas, Richard Weltzin, Paul J. Giannasca, et al.. (1996). Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting.. The Journal of Experimental Medicine. 184(3). 1045–1059. 313 indexed citations
19.
Frey, Andreas, et al.. (1990). Synthesis of Apolipoprotein A‐1 in Pig Brain Microvascular Endothelial Cells. Journal of Neurochemistry. 54(2). 444–450. 49 indexed citations
20.
Möckel, Babette, et al.. (1989). cDNA Cloning and Sequence Analysis of the Glucose Transporter from Porcine Blood-Brain Barrier. Biological Chemistry Hoppe-Seyler. 370(1). 467–474. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026